Arbeitspapier
Market structure, R&D and advertising in the pharmaceutical industry
Recent developments in the literature on market structure have allowed the generation of a few key testable predictions from the theory of strategic behaviour. The seminal model considers one simple but general relationship, that between market structure and market size, focusing on the competitive roles of the endogenous sunk costs of advertising and/or research and development (R&D). Evidence presented in this case study, building on earlier econometric work, shows that such endogenous sunk costs do play a crucial role in the formation of market structure in the global pharmaceutical industry.
- Language
-
Englisch
- Bibliographic citation
-
Series: WZB Discussion Paper ; No. FS IV 98-17
- Classification
-
Wirtschaft
- Event
-
Geistige Schöpfung
- (who)
-
Matraves, Catherine
- Event
-
Veröffentlichung
- (who)
-
Wissenschaftszentrum Berlin für Sozialforschung (WZB)
- (where)
-
Berlin
- (when)
-
1998
- Handle
- Last update
-
10.03.2025, 11:43 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Arbeitspapier
Associated
- Matraves, Catherine
- Wissenschaftszentrum Berlin für Sozialforschung (WZB)
Time of origin
- 1998
Other Objects (12)
Advertising, Competition, and Regulation in the Pharmaceutical Industry
R&D Spin-outs in the pharmaceutical industry
Choosing R&D or advertising for competing firms in uncertain market
Direct to consumer advertising in pharmaceutical markets
Simultaneous Determinants of Market Share and Advertising Expenditure under Dynamic Conditions: The Case of a Firm within the Japanese Pharmaceutical Industry
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
Advertising regulations in pharmaceutical markets: Product versus enlightenment
The Impact of Governmental Policy on R&D Projects in the Pharmaceutical Industry
Innovation, search, and the success of R&D projects in the pharmaceutical industry
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry
The TV industry: Advertising and programming
Advertising, Competition, and Regulation in the Pharmaceutical Industry
R&D Spin-outs in the pharmaceutical industry
Choosing R&D or advertising for competing firms in uncertain market
Direct to consumer advertising in pharmaceutical markets
Simultaneous Determinants of Market Share and Advertising Expenditure under Dynamic Conditions: The Case of a Firm within the Japanese Pharmaceutical Industry
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
Advertising regulations in pharmaceutical markets: Product versus enlightenment
The Impact of Governmental Policy on R&D Projects in the Pharmaceutical Industry
Innovation, search, and the success of R&D projects in the pharmaceutical industry
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry
The TV industry: Advertising and programming
Advertising, Competition, and Regulation in the Pharmaceutical Industry
R&D Spin-outs in the pharmaceutical industry
Choosing R&D or advertising for competing firms in uncertain market
Direct to consumer advertising in pharmaceutical markets
Simultaneous Determinants of Market Share and Advertising Expenditure under Dynamic Conditions: The Case of a Firm within the Japanese Pharmaceutical Industry
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
Advertising regulations in pharmaceutical markets: Product versus enlightenment
The Impact of Governmental Policy on R&D Projects in the Pharmaceutical Industry
Innovation, search, and the success of R&D projects in the pharmaceutical industry
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry